Variables | Cognitive dysfunction | P value | |
---|---|---|---|
Normal (n = 63) | Dysfunction (n = 29) | ||
Age | 37.32 ± 8.57 | 39.14 ± 8.79 | 0.516 |
Education time | 13.87 ± 2.41 | 12.50 ± 3.94 | 0.244 |
Gender | |||
Male | 28 (44.4%) | 19 (65.5%) | 0.075 |
Female | 35 (55.6%) | 10 (34.5%) | |
Clinical type | |||
Ischemic | 47 (74.6%) | 17 (58.6%) | 0.147 |
Hemorrhagic | 16 (25.4%) | 12 (41.4%) | |
Suzuki stage (left) | 0.208 | ||
I | 3 (4.8%) | 2 (6.9%) | 0.649 |
II | 5 (8.1%) | 8 (27.6%) | 0.021* |
III | 15 (24.2%) | 6 (20.7%) | 0.796 |
IV | 11 (17.7%) | 5 (17.2%) | 0.615 |
V | 26 (41.3%) | 8 (27.6%) | 0.206 |
VI | 3 (4.8%) | 1 (3.4%) | 0.774 |
Suzuki stage (right) | 0.555 | ||
I | 11 (17.5%) | 6 (20.7%) | 0.711 |
II | 5 (7.9%) | 4 (13.8%) | 0.456 |
III | 8 (12.7%) | 5 (17.2%) | 0.539 |
IV | 18 (28.6%) | 4 (13.8%) | 0.123 |
V | 19 (30.2%) | 8 (27.6%%) | 0.801 |
VI | 2 (3.2%) | 2 (6.9%) | 0.588 |